Dr. Konstan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave Department of Pediatrics-Pulmonary
Cleveland, OH 44106Phone+1 216-844-1750Fax+1 216-844-7960- Is this information wrong?
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
- University at BuffaloResidency, Pediatrics, 1982 - 1985
- Case Western Reserve University School of MedicineClass of 1982
Certifications & Licensure
- OH State Medical License 1982 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Northern Ohio Live Castle Connolly, 2006-2009
Clinical Trials
- Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis Start of enrollment: 1996 Aug 01
- A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis Start of enrollment: 2000 Feb 01
- Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung Disease Start of enrollment: 2006 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCorrigendum to FEV1 Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function [The Journal of Pediatrics (2016) 116-121].Wayne J Morgan, Donald R VanDevanter, David J Pasta, Aimee J Foreman, Jeffrey S Wagener, Michael W Konstan> ;The Journal of Pediatrics. 2023 Apr 1
- Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.Gregory S Sawicki, Michael W Konstan, Edward F McKone, Richard B Moss, Barry Lubarsky, Ellison Suthoff, Stefanie J Millar, David J Pasta, Nicole Mayer-Hamblett, Christ...> ;Pulmonary Therapy. 2022 Dec 1
- 2 citationsForming Cardi-OH: A Statewide Collaborative to Improve Cardiovascular Health in Ohio.Shari D Bolen, Elizabeth A Beverly, Shireen Khoury, Saundra Regan, Jackson T Wright Jr, Siran Koroukian, Randell Wexler, Goutham Rao, Daniel Hargraves, Dean Bricker, G...> ;Cureus. 2022 Aug 1
- Join now to see all
Journal Articles
- Opportunities for Life Course Research Through the Integration of Data Across Clinical and Translational Research InstitutesMichael W Konstan, Shari L Barkin, James E Heubi, Journal of Clinical and Translational Science
Press Mentions
- First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to Be Presented at the 2023 Digestive Disease Week (DDW) ConferenceFebruary 21st, 2023
- #NACFC2022 – LAU-7b May Prevent Lung Function Decline in CFNovember 9th, 2022
- AzurRx BioPharma Announces Formation of Scientific Advisory BoardOctober 21st, 2020
- Join now to see all
Grant Support
- Research Career Development In Child HealthEunice Kennedy Shriver National Institute Of Child Health &Human Development2011–2012
- Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
- PTC124 As An Oral Treatment For Nonsense-Mutation-Mediated Cystic FibrosisNational Center For Research Resources2006
- Tobramycin For Inhalation (TOBI) In Young Children With Cystic FibrosisNational Center For Research Resources2005
- Oral Theraclec-Total In CF Patients With Exocrine Pancreatic InsufficiencyNational Center For Research Resources2005
- Biil284bs In Adult And Pediatric Cystic Fibrosis PatientsNational Center For Research Resources2004–2005
- Oral Theraclec-Total In Adult And Pediatric Subjects With Cystic FibrosisNational Center For Research Resources2004
- Neutrophil Imaging Of The Lung For Characterizing Pulmonary Infection In CF PTSNational Center For Research Resources2004
- Fat And Protein Absorption In Cystic Fibrosis PTS With Pancreatic InsufficiencyNational Center For Research Resources2004
- Lower Airway Deposit Of Inhaled Tobramycin In Cystic FibNational Center For Research Resources2000–2002
- Ins365 In Adult &Pediatric Cystic FibrosisNational Center For Research Resources2000–2002
- Ib367 In Adult Patients With Cystic FibrosisNational Center For Research Resources2000–2002
- Free Elastase Concentration In BAL Fluid In Cystic FibrosisNational Center For Research Resources2000–2002
- Lung Specific Bioefficacy Of Oral DMP 777 In Adults W/ CFNational Center For Research Resources1999–2002
- CPX (Oral, Multidose) In Adults W/ Mild To Moderately Severe Cystic FNational Center For Research Resources1999–2002
- Dmp777 In Adult Patients 18 Yrs Of Age And Older With Cystic FibrosisNational Center For Research Resources1998–2000
- CPX In Adult Patients With Mild Cystic FibrosisNational Center For Research Resources1998–2000
- Prolastin Aerosol Therapy In Patients With Cystic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
- In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994–2000
- Trial In Patients With Mild Cystic Fibrosis To Determine Efficacy Of PulmozymeNational Center For Research Resources1996–1997
- Bronchoalveolar Lavage Studies In Cystic FibrosisNational Center For Research Resources1996–1997
- Inhalation Administration Of Alpha1-Pl By Aerosol In Cystic FibrosisNational Center For Research Resources1996
- In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1992–1996
- Pharmacokinetics Of Tobramycin Administered By Different Nebulizers To CF PTSNational Center For Research Resources1995
- Pilot Study--Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
- Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1994
- Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994
- Secretory Leukocyte Protease Inhibitor Augmentation Therapy In CF PatientsNational Center For Research Resources1993
- Intravenous Elastase Inhibitor In Stable Cyctic Fibrosis OutpatientsNational Center For Research Resources1993
- Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1992–1993
- Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1990–1993
- Pilot Study-- Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1991
Hospital Affiliations
- University Hospitals Cleveland Medical CenterCleveland, Ohio
- UH Rainbow Babies and Childrens HospitalCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: